IL6 and rheumatoid arthritis: In RA patients, Treg cells are reduced in number and impaired in function, and IL-6 in the inflammatory microenvironment further inhibits the expression of the Treg cell transcription factor Foxp3, which promotes the differentiation of Th17 cells and impairs their inhibitory effects on OC production and bone resorption (32, 33).